Opiant Pharmaceuticals to present at Jefferies Virtual London Healthcare Conference

SANTA MONICA, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") OPNT, a company advancing medicines to better treat addictions and drug overdose, today announced that members of the company's senior management team will participate in the 12^th Jefferies London Healthcare Conference virtually on Thursday, November 18 and Friday, November 19. Management will participate in investor 1x1 meetings on both days. A webcast of the event will be available from November 18, 2021, 8:00 AM GMT / 3:00 AM ET on the Opiant website.

About Opiant Pharmaceuticals, Inc. 

Opiant Pharmaceuticals, Inc., the company that developed NARCAN^® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com.

For Media and Investor Inquiries:

Ben Atkins, Opiant

(310) 598-5410

batkins@opiant.com